These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 749908)

  • 41. Active specific immunotherapy of human solid tumors.
    Rosato FE; Miller E; Rosato EF
    Va Med; 1978 Mar; 105(3):221-3. PubMed ID: 636545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells.
    Glück R; Hoskins JM; Wegmann A; Just M; Germanier R
    Dev Biol Stand; 1986; 65():29-35. PubMed ID: 3556774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Subsets of peripheral blood lymphocytes and tumor infiltrating lymphocytes in cancer patients received chemotherapy].
    Mitachi Y; Murakawa Y; Okuno M; Kambe M; Kanamaru R; Takahasi H; Wakui A
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):482-8. PubMed ID: 2138871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro augmentation of cytotoxicity against tumor cell lines by mumps virus.
    Morales A; Ottenhof P; Elliott M
    Invest Urol; 1980 Jan; 17(4):284-7. PubMed ID: 6927978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [5 years' experience in the immunotherapy of human cancer].
    Humphrey LJ; Boehm OR; Boehm BJ; Jewell WR
    Zentralbl Chir; 1973 Sep; 98(35):1241-6. PubMed ID: 4784998
    [No Abstract]   [Full Text] [Related]  

  • 46. Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study.
    Stemmler HJ; Salat C; Lindhofer H; Menzel H; Untch M; Kahlert S; Konecny G; Sauer H; Ledderose G; Heinemann V; Kolb HJ
    Anticancer Res; 2005; 25(4):3047-54. PubMed ID: 16080564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion.
    Morisaki T; Matsumoto K; Kuroki H; Kubo M; Baba E; Onishi H; Tasaki A; Nakamura M; Inaba S; Katano M
    Anticancer Res; 2003; 23(6a):4459-65. PubMed ID: 14666734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NTP Toxicology and Carcinogenesis Studies of 2,2-Bis(Bromomethyl)-1,3-Propanediol (FR-1138(R)) (CAS No. 3296-90-0) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 May; 452():1-465. PubMed ID: 12594523
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy.
    Andreesen R; Scheibenbogen C; Brugger W; Krause S; Meerpohl HG; Leser HG; Engler H; Löhr GW
    Cancer Res; 1990 Dec; 50(23):7450-6. PubMed ID: 1701343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NTP Toxicology and Carcinogenesis Studies of 2,3-Dibromo-1-Propanol (CAS No. 96-13-9) in F344/N Rats and B6C3F1 Mice (Dermal Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Dec; 400():1-202. PubMed ID: 12563345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Mumps virus therapy of neoplasms (1)].
    Okuno Y; Asada T; Yamanishi K; Otsuka E; Takahashi M
    Nihon Rinsho; 1977 Sep; 35(9):2867-72. PubMed ID: 926384
    [No Abstract]   [Full Text] [Related]  

  • 53. [Controversial problems in current clinical oncology].
    Gritsman IuIa; Shubin BM; Mamontov AS
    Sov Med; 1977 Aug; (8):16-22. PubMed ID: 562537
    [No Abstract]   [Full Text] [Related]  

  • 54. [Attempted therapy of incurable oncologic patients with adenovirus type 16].
    Svet-Moldavskii GIa; Gibadulin RA; Frol'tsova AE; Gamburg VP; Perevodchikova NI
    Vopr Virusol; 1974; (6):713-9. PubMed ID: 4446571
    [No Abstract]   [Full Text] [Related]  

  • 55. [Current problems of the control of neoplasms in later life (author's transl)].
    Berndt H
    Z Alternsforsch; 1979; 34(4):315-9. PubMed ID: 547513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Local tumor immunotherapy with in vitro activated autochithonous lymphocytes.
    Cheema AR; Hersh EM
    Cancer; 1972 Apr; 29(4):982-6. PubMed ID: 4552815
    [No Abstract]   [Full Text] [Related]  

  • 57. [Evaluation of the functional state in the treatment of oncologic patients].
    Peterson BE; Pavlova ZV; Zaĭtsev VF; Kachalov VK
    Vestn Akad Med Nauk SSSR; 1968; 23(6):31-41. PubMed ID: 5746007
    [No Abstract]   [Full Text] [Related]  

  • 58. Assessment of the exfoliation of tumor cells into the body cavities.
    MOORE GE; SAKO K; KONDO T; BADILLO J; BURKE E
    Surg Gynecol Obstet; 1961 Apr; 112():469-74. PubMed ID: 13772295
    [No Abstract]   [Full Text] [Related]  

  • 59. Triple-Negative Breast Cancer: Basic Biology and Immuno-Oncolytic Viruses.
    Monaco ML; Idris OA; Essani K
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comprehensive assessment on the applications of oncolytic viruses for cancer immunotherapy.
    Omole RK; Oluwatola O; Akere MT; Eniafe J; Agboluaje EO; Daramola OB; Ayantunji YJ; Omotade TI; Torimiro N; Ayilara MS; Adeyemi OI; Salinsile OS
    Front Pharmacol; 2022; 13():1082797. PubMed ID: 36569326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.